Most bought healthcare stocks in Q4 2023
See which Healthcare stocks institutional investors increased the most in Q4 2023, measured as net growth in reported share positions from Q3 2023 into Q4 2023. Notable additions at the top of this list include BAXTER INTERNATIONAL INC (BAX), AVANTOR INC (AVTR), RECURSION PHARMACEUTICALS-A (RXRX), ZIMMER BIOMET HOLDINGS INC (ZBH). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | 36,147,188 | $1.41B | 0 | 5 | 3 | 0 | 9 |
| AVTR | AVANTOR INC | 35,012,949 | $1.05B | 0 | 2 | 1 | 2 | 5 |
| RXRX | RECURSION PHARMACEUTICALS-A | 13,777,689 | $151.05M | 0 | 1 | 0 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 6,873,429 | $890.46M | 0 | 5 | 3 | 0 | 9 |
| LFST | LIFESTANCE HEALTH GROUP INC | 6,001,312 | $49.57M | 0 | 1 | 0 | 1 | 1 |
| CVS | CVS HEALTH CORP | 5,121,949 | $623.36M | 4 | 3 | 4 | 1 | 12 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 4,355,211 | $89.47M | 0 | 1 | 0 | 1 | 1 |
| VTRS | VIATRIS INC | 3,361,078 | $37.13M | 2 | 0 | 1 | 0 | 4 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 3,141,316 | $427.57M | 1 | 2 | 2 | 1 | 8 |
| NVST | ENVISTA HOLDINGS CORP | 2,799,964 | $22.02M | 0 | 2 | 0 | 0 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | 2,395,645 | -$103.21M | 0 | 6 | 2 | 0 | 10 |
| DOCS | DOXIMITY INC-CLASS A | 2,244,140 | $56.33M | 2 | 1 | 1 | 0 | 4 |
| NVRO | NEVRO CORP | 2,197,547 | $46.66M | 1 | 1 | 0 | 0 | 2 |
| BLUE | BLUEBIRD BIO INC | 2,190,885 | $39.58K | 1 | 1 | 0 | 0 | 2 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 2,179,400 | $744 | 0 | 1 | 0 | 0 | 1 |
| VERV | VERVE THERAPEUTICS INC | 1,989,116 | $28.97M | 1 | 1 | 0 | 0 | 2 |
| NKTR | NEKTAR THERAPEUTICS | 1,818,794 | $920 | 0 | 1 | 0 | 0 | 1 |
| HLN | HALEON PLC-ADR | 1,804,981 | -$2.00M | 0 | 4 | 2 | 0 | 6 |
| RCM | R1 RCM INC | 1,799,098 | $19.02K | 1 | 0 | 0 | 0 | 1 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,623,956 | $2.33K | 0 | 1 | 0 | 0 | 1 |
| HRTX | HERON THERAPEUTICS INC | 1,592,000 | $2.90K | 0 | 1 | 0 | 0 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,553,135 | $9.08K | 0 | 1 | 0 | 0 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,477,217 | $33.39M | 1 | 1 | 0 | 0 | 2 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,444,524 | $142.04M | 0 | 2 | 0 | 0 | 2 |
| TDOC | TELADOC HEALTH INC | 1,278,892 | $79.81M | 0 | 2 | 0 | 0 | 2 |
| ERAS | ERASCA INC | 1,266,400 | $2.82K | 0 | 1 | 0 | 0 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,246,005 | -$16.47M | 0 | 1 | 0 | 1 | 2 |
| PSNL | PERSONALIS INC | 1,240,454 | $7.09M | 0 | 2 | 0 | 0 | 2 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 1,233,977 | $720 | 0 | 1 | 0 | 0 | 1 |
| ESPR | ESPERION THERAPEUTICS INC | 1,213,944 | $4.04K | 0 | 1 | 0 | 0 | 1 |
| BSX | BOSTON SCIENTIFIC CORP | 1,171,461 | $73.95M | 0 | 4 | 1 | 0 | 5 |
| DXCM | DEXCOM INC | 1,156,760 | $143.42M | 2 | 1 | 0 | 1 | 3 |
| JNJ | JOHNSON & JOHNSON | 1,108,941 | -$84.11M | 1 | 7 | 6 | 1 | 18 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,098,780 | -$2.60K | 0 | 1 | 0 | 0 | 1 |
| NUVB | NUVATION BIO INC | 1,093,131 | $655.62K | 0 | 1 | 0 | 0 | 3 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,086,892 | $9.87K | 0 | 1 | 0 | 0 | 1 |
| QSI | QUANTUM-SI INC | 1,071,105 | $7.21M | 0 | 1 | 0 | 0 | 1 |
| TXG | 10X GENOMICS INC-CLASS A | 1,047,827 | $102.67M | 0 | 1 | 0 | 0 | 1 |
| GOSS | GOSSAMER BIO INC | 1,007,001 | $14.70K | 1 | 1 | 0 | 0 | 2 |
| BFLY | BUTTERFLY NETWORK INC | 999,060 | -$220.38K | 0 | 2 | 0 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 966,993 | $2.56M | 0 | 2 | 0 | 0 | 2 |
| CDNA | CAREDX INC | 957,217 | $46.13M | 0 | 3 | 0 | 0 | 3 |
| SENS | SENSEONICS HOLDINGS INC | 912,100 | $520 | 1 | 0 | 0 | 0 | 1 |
| MCK | MCKESSON CORP | 896,033 | $481.28M | 2 | 3 | 1 | 1 | 6 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 886,636 | $2.53M | 0 | 2 | 0 | 0 | 2 |
| OGN | ORGANON & CO | 882,849 | $2.27M | 0 | 1 | 1 | 2 | 2 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 846,582 | $98.37M | 2 | 4 | 0 | 1 | 6 |
| HCA | HCA HEALTHCARE INC | 840,700 | $344.74M | 3 | 2 | 2 | 1 | 7 |
| MCRB | SERES THERAPEUTICS INC | 817,000 | $1.14K | 1 | 0 | 0 | 0 | 1 |
| ACCD | ACCOLADE INC | 811,185 | $17.80M | 0 | 2 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q4 2023
What are the most bought Healthcare stocks in Q4 2023?
The most bought healthcare stocks in Q4 2023 are those with the largest increase in reported share counts across tracked institutional investors compared to Q3 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2023?
Among the managers we track, net additions were largest in companies such as BAXTER INTERNATIONAL INC (BAX), AVANTOR INC (AVTR), RECURSION PHARMACEUTICALS-A (RXRX), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2023).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.